If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
5,140.00    182.00 (3.67%)
Bid:
5,100.00
Ask:
5,110.00
Spread: 10.00 (0.196%)
Market Cap: £18.73b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Director Declaration

2 Jul 2026 12:20

RNS Number : 8205K
Coca-Cola HBC AG
02 July 2026
Β 

Coca-Cola HBC AG

Director Declaration

Β 

Zug, Switzerland - 2 July 2026 - Coca-Cola HBC AG ("Coca-Cola HBC") announces that Glykeria Tsernou, who is an independent non-executive director of Coca-Cola HBC, has been appointed to the board of Attica Department Stores SA.

Attica Department Stores SA shares have been listed and effective 2 July 2026 commenced trading on Euronext Athens. Glykeria Tsernou is an independent non-executive director, a member of the audit committee and a member of the remuneration and nomination committee of Attica Department Stores SA and has been appointed in these positions prior to Attica Department Stores SA's listing.

This disclosure is made in accordance with the Financial Conduct Authority's UK Listing Rule 6.4.9R.

Β 

Β 

Enquiries

Coca-Cola HBC Group

Investors and Analysts:

Jemima Benstead

Head of Investor Relations

Tel: +44 7740 535130

Β jemima.benstead @cchellenic.com

Elias Davvetas

Investor Relations Manager

Tel: +30 694 7568826

elias.davvetas@cchellenic.com

Matilde Durazzano

Investor Relations Manager

Β 

Elizabeth King

Investor Relations Manager

Β 

Tel: +44 7851 105884

matilde.durazzano@cchellenic.com

Β 

Tel: +44 7864 686582

elizabeth.king@cchellenic.com

Media:

Claire Evans

Head of Corporate Communications

Tel: +44 7896 054 972

claire.evans @cchellenic.com

Β 

About Coca‑Cola HBC

Coca-Cola HBC is a growth-focused consumer packaged goods business and strategic bottling partner of

The Coca-Cola Company. We open up moments that refresh us all, by creating value for our stakeholders and supporting the socio-economic development of the communities in which we operate. With a vision to be the leading 24/7 beverage partner, we offer drinks for all occasions around the clock and work together with our customers to serve 760 million consumers across a broad geographic footprint of 29 countries. Our portfolio is one of the strongest, broadest and most flexible in the beverage industry, with consumer-leading brands across the sparkling, adult sparkling, juice, water, sport, energy, ready-to-drink tea, coffee, and premium spirits categories, with snacks as an additional offering. Our products include Coca-Cola, Coca-Cola Zero Sugar, Fanta, Sprite, Schweppes, Kinley, Costa Coffee, Caffè Vergnano, Valser, FuzeTea, Powerade, Cappy, Monster Energy, Finlandia Vodka, The Macallan, Jack Daniel's and Plazma. We foster an open and inclusive work environment for our more than 33,500 employees and believe that a positive environmental impact is integral to our future growth. We are among the leaders of the global beverage industry across major sustainability benchmarks, including the Dow Jones Best-in-Class Indices, CDP, MSCI ESG, FTSE ESG and ISS ESG.

Β 

Coca-Cola HBC is listed on the London Stock Exchange (LSE: CCH) and on Euronext Athens (Euronext Athens: EEE). For more information, please visit https://www.coca-colahellenic.com

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RDNBGGDRRUGDGLD
Date   Source Headline
6th Jun 201612:00 pmRNSStrategy/Company/Ops Update
31st May 20163:28 pmRNSDirector Declaration
25th May 20169:55 amRNSDirector/PDMR Shareholding
25th May 20169:49 amRNSDirector/PDMR Shareholding
19th May 20167:30 amRNSNotice of AGM
17th May 20168:02 amRNSChanges to the BoD and Confirms Dividend Dates
13th May 20167:00 amRNSA GOOD START TO THE YEAR
3rd May 20169:17 amRNSBlock listing Interim Review
29th Apr 201611:46 amRNSCoca-Cola HBC Finance BV Annual Report 2015
18th Apr 201610:23 amRNSNotice of Results
1st Apr 20167:15 amRNSIssue of Equity and Total Voting Rights
30th Mar 201611:19 amRNSDirector/PDMR Shareholding
17th Mar 20161:21 pmRNSDirector/PDMR Shareholding
17th Mar 201610:49 amRNS2015 Integrated Annual Report
11th Mar 201610:24 amRNSDirector/PDMR Shareholding
10th Mar 201612:24 pmRNSSettlement of New Issue of Notes
10th Mar 201610:34 amRNSANNOUNCEMENT OF RESULTS
10th Mar 201610:09 amRNSINVITATION TO PURCHASE NOTES FOR CASH
8th Mar 20166:07 pmRNSPublication of Final Terms
8th Mar 20165:56 pmRNSPublication of Final Terms (replacement)
8th Mar 20165:32 pmRNSPublication of Final Terms
8th Mar 20163:38 pmRNSDirector/PDMR Shareholding
3rd Mar 20165:39 pmRNSLaunch of Issue of Notes
3rd Mar 20165:35 pmRNSPricing of Issue of Notes
3rd Mar 20169:30 amRNSIssue of Debt
3rd Mar 20169:24 amRNSTender Offer
1st Mar 20167:00 amRNSIssue of Equity and Total Voting Rights
29th Feb 201610:46 amRNSDirector/PDMR Shareholding
19th Feb 20162:29 pmRNSSUPPLEMENTARY PROSPECTUS DATED 19 FEBRUARY 2016
19th Feb 20162:15 pmRNSPublication of supplementary prospectus
19th Feb 20167:00 amRNSEXECUTION DRIVES TOP-LINE AND MARGIN EXPANSION
28th Jan 20167:00 amRNSAppointment of Anastassis G. David as Chairman
22nd Jan 20168:27 amRNSNotice of Results
12th Jan 20161:39 pmRNSHolding(s) in Company
12th Jan 20161:25 pmRNSAthens Exchange trading date of ordinary shares
4th Jan 20167:00 amRNSIssue of Equity and Total Voting Rights
22nd Dec 20157:00 amRNSTransaction in Own Shares
21st Dec 20157:02 amRNSTransaction in Own Shares
18th Dec 201510:28 amRNSHolding(s) in Company
18th Dec 20157:00 amRNSTransaction in Own Shares
17th Dec 20157:00 amRNSTransaction in Own Shares
16th Dec 20157:00 amRNSTransaction in Own Shares
15th Dec 20157:00 amRNSTransaction in Own Shares
14th Dec 20157:00 amRNSTransaction in Own Shares
11th Dec 20152:57 pmRNSDirector/PDMR Shareholding
11th Dec 201511:01 amRNSRe-appointment of Auditor
11th Dec 20157:00 amRNSTransaction in Own Shares
10th Dec 20157:00 amRNSTransaction in Own Shares
9th Dec 20157:00 amRNSTransaction in Own Shares
7th Dec 20157:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.